These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24801648)

  • 1. CD40 expression in renal cell carcinoma is associated with tumor apoptosis, CD8(+) T cell frequency and patient survival.
    Weiss JM; Gregory Alvord W; Quiñones OA; Stauffer JK; Wiltrout RH
    Hum Immunol; 2014 Jul; 75(7):614-20. PubMed ID: 24801648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40 Cross-Linking Induces Migration of Renal Tumor Cell through Nuclear Factor of Activated T Cells (NFAT) Activation.
    Pontrelli P; Gigante M; Spadaccino F; Netti GS; Saldarelli M; Balducci L; Gigante M; Battaglia M; Storkus WJ; Castellano G; Stallone G; Gesualdo L; Ranieri E
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized controlled trial.
    Choueiri TK; Figueroa DJ; Fay AP; Signoretti S; Liu Y; Gagnon R; Deen K; Carpenter C; Benson P; Ho TH; Pandite L; de Souza P; Powles T; Motzer RJ
    Clin Cancer Res; 2015 Mar; 21(5):1071-7. PubMed ID: 25538263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of galactosylceramide-sulfotransferase (Gal3ST1) in human renal cell carcinoma.
    Porubsky S; Nientiedt M; Kriegmair MC; Siemoneit JH; Sandhoff R; Jennemann R; Borgmann H; Gaiser T; Weis CA; Erben P; Hielscher T; Popovic ZV
    Sci Rep; 2021 May; 11(1):10926. PubMed ID: 34035403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seminal plasma protein in renal cell carcinoma: expression of semenogelin I is a predictor for cancer progression and prognosis.
    Zhang S; Fang J; Zhang X; Qin C; Su S; Deng Y; Song Z; Zhang Y; Wang H; Yin C; Wang Z
    Tumour Biol; 2014 Sep; 35(9):9095-100. PubMed ID: 25027395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of keratin 14 expression measurement in reflecting the tumor properties and prognosis in patients with renal cell carcinoma: a study with long-term follow-up.
    Wang S; Gao P; Wang X; Duan L; He X; Qu J
    Int Urol Nephrol; 2024 Jun; 56(6):2045-2053. PubMed ID: 38206525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis.
    Pan X; Li Z; Zhao L; Quan J; Zhou L; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Lai Y
    Oncol Rep; 2018 Nov; 40(5):3092-3101. PubMed ID: 30132566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.
    Gremel G; Djureinovic D; Niinivirta M; Laird A; Ljungqvist O; Johannesson H; Bergman J; Edqvist PH; Navani S; Khan N; Patil T; Sivertsson Å; Uhlén M; Harrison DJ; Ullenhag GJ; Stewart GD; Pontén F
    BMC Cancer; 2017 Jan; 17(1):9. PubMed ID: 28052770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G-protein-coupled receptor CLR is upregulated in an autocrine loop with adrenomedullin in clear cell renal cell carcinoma and associated with poor prognosis.
    Nikitenko LL; Leek R; Henderson S; Pillay N; Turley H; Generali D; Gunningham S; Morrin HR; Pellagatti A; Rees MC; Harris AL; Fox SB
    Clin Cancer Res; 2013 Oct; 19(20):5740-8. PubMed ID: 23969937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma.
    Sekino Y; Han X; Kobayashi G; Babasaki T; Miyamoto S; Kobatake K; Kitano H; Ikeda K; Goto K; Inoue S; Hayashi T; Teishima J; Sakamoto N; Sentani K; Oue N; Yasui W; Matsubara A
    Oncology; 2021; 99(4):240-250. PubMed ID: 33588420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma.
    Ishizaki H; Yano H; Tsuneoka M; Ogasawara S; Akiba J; Nishida N; Kojiro S; Fukahori S; Moriya F; Matsuoka K; Kojiro M
    Pathol Int; 2007 Oct; 57(10):672-80. PubMed ID: 17803656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tim-3 expression represents dysfunctional tumor infiltrating T cells in renal cell carcinoma.
    Cai C; Xu YF; Wu ZJ; Dong Q; Li MY; Olson JC; Rabinowitz YM; Wang LH; Sun Y
    World J Urol; 2016 Apr; 34(4):561-7. PubMed ID: 26253654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
    Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
    Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fc receptor-like A promotes malignant behavior in renal cell carcinoma and correlates with tumor immune infiltration.
    Liu JP; Jiang YF; Liu JW; Tian CJ; Lin YZ; Yang YZ; Zhang ZK; Fang YL; Huang B; Lin H
    Cancer Med; 2024 Aug; 13(15):e70072. PubMed ID: 39108036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
    Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
    Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of cyclooxygenase-1 correlates with poor prognosis in renal cell carcinoma.
    Yu ZH; Zhang Q; Wang YD; Chen J; Jiang ZM; Shi M; Guo X; Qin J; Cui GH; Cai ZM; Gui YT; Lai YQ
    Asian Pac J Cancer Prev; 2013; 14(6):3729-34. PubMed ID: 23886173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction.
    Gigante M; Pontrelli P; Herr W; Gigante M; D'Avenia M; Zaza G; Cavalcanti E; Accetturo M; Lucarelli G; Carrieri G; Battaglia M; Storkus WJ; Gesualdo L; Ranieri E
    J Transl Med; 2016 Apr; 14():84. PubMed ID: 27063186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of centromere protein H is associated with progression of renal cell carcinoma.
    Wu X; Lin Y; Shi L; Huang Y; Lai C; Wang Y; Zhang M; Wang S; Heng B; Yu G; Du X; Fang L; Fu Y; Chen J; Guo Z; Su Z; Wu S
    J Mol Histol; 2015 Oct; 46(4-5):377-85. PubMed ID: 26248586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMPORTANCE OF APOPTOSIS MARKERS (MDM2, BCL-2 AND Bax) IN CONVENTIONAL RENAL CELL CARCINOMA.
    Saker Z; Tsintsadze O; Jiqia I; Managadze L; Chkhotua A
    Georgian Med News; 2015 Dec; (249):27-33. PubMed ID: 26719546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma.
    Girgis H; Masui O; White NM; Scorilas A; Rotondo F; Seivwright A; Gabril M; Filter ER; Girgis AH; Bjarnason GA; Jewett MA; Evans A; Al-Haddad S; Siu KM; Yousef GM
    Mol Cancer; 2014 May; 13():101. PubMed ID: 24885701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.